News

RSS feed

Genethon Lecture Series: 2014, April 3rd

Thursday April 3rd, 2014: “Gene Therapy for Haemophilia B” Prof. Amit Nathwani (Centre Director of the Katharine Dormandy Haemophilia Centre, Katharine Dormandy Haemophilia Centre and Thrombosis Unit. Royal Free Hospital , London, United Kingdom)

Genethon Lecture Series:2013, December 13th

Friday December 13th, 2013: « Causes of rimmed vacuolar muscle diseases – and the example of mutated DNAJB6 » Pr Bjarne Udd (Tampere University and University Hospital, Neuromuscular Research Unit, Tampere, Finland).

Genethon Lecture Series:2013, December 12th

Le jeudi 12 décembre 2013 : « Gene therapy of mucopolysaccharidosis IIIA » Pr Fatima Bosch (Professor of the Faculty of the Universitat Autonoma de Barcelona and Director of the CBATEG (Center of Animal Biotechnology and Gene Therapy), Bellatera, Barcelona, Spain

Genethon Lecture Series:2013, November 22th

Friday November 22th, 2013: « Role of autophagy in muscular dystrophies and in cardiomyopathies » Marco Sandri, MD (University of Padova, Department of Biomedical Science, Italy and Dulbecco Telethon Institute at Venetian Institute of Molecular Medicine, Padova, Italy)

Genethon Bioprod has been certified as a pharmaceutical manufacturer (Le Republicain)

Read the article (PDF in French)

French medicines for Telethon patients (Pelerin)

Read the article (PDF in French)
Article of Sophie Laurant, in Pèlerin n°6815 (July 11th 2013) – www.pelerin.com

Green light from ANSM for Genethon (Industrie Pharma)

The AFM-Telethon laboratory has been certified as a pharmaceutical manufacturer by ANSM, thus becoming the first not-for-profit laboratory.

Genethon BioProd invents medicines of the future (Figaro Magazine)

Unique in the world, this laboratory, financed by the Telethon, has just opened south of Paris. It will manufacture products for  gene therapy treatments on a large scale.

The Telethon can commercialize medicines (Le Point.fr)

The organizer of the Telethon enters the industrial era (Le Monde Economie)